BMS, “Targeted combination therapies are the best for cancer patients”
BMS Pharmaceutical recommended combined targeted therapies as the best treatment for cancer patients, and announced a plan to continue and extend researches related to this.
On the 16th, BMS Pharmaceutical Korea revealed the BMS’s development process of targeted therapies and pipelines for spec...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
